Abbott Korea to stop sales of Reductil

Abbott Korea said on October 14 it will suspend Korea sales of a weight- loss pill in the face of a recommendation by the Korea Food and Drug Administration that heart-related risks made the prescription drug too dangerous.

The drug agency urged a halt to sales of drugs containing sibutramine, which are sold under the names Reductil, Reduxade and Zelium in Europe and Meridia in the United St...